Skip to main content
Blue @ Work

Determining a drug’s true value

Considering more than just total cost

If you’ve glanced at the headlines lately, you’ve probably noticed that prescription drug prices are trending upward,* and don’t show too many signs of changing course.

See image description

Though “bending the trend” of pharmacy involves many different components, Wellmark Blue Cross and Blue Shield is able to positively influence the Wellmark Drug List Opens in a new window, which is one piece toward creating a sustainable health care system. To do this, Wellmark evaluates drugs based not just on total cost, but rather the drug’s true value.

True value

A drug’s true value takes into account safety, effectiveness, and relative cost when assigning a drug to a specific level or tier within the Wellmark Drug List. Consider two common prescription drugs that treat diabetes. Metformin and Glumetza® are both safe and high-performing when evaluated for controlling blood sugar and the prevention of diabetes. However, metformin costs much less when compared to the other drug options. In this instance, metformin is a best buy and your best bet.

HTMLSee image description

By emphasizing these three criteria — safety, effectiveness and relative cost — we’re able to better protect your employees’ health in the long run. It’s part of Wellmark’s commitment to make the right choice the easy choice.

Learn more about the different ways you can personalize your pharmacy benefits program in order to best serve your employees and your organization’s bottom line:

*While these high prices are usually linked to brand-name or specialty drugs, they do influence the overall trend of health care spending.